SA
Sign upLog In

Inhibrx Biosciences Inc (INBX)

Cost of Revenue

$1.68M

TTM · Period ending: · USD

INBX logo

INBX Cost of Revenue

Latest reported$1.68M
INBX TTM Cost of Revenue ($31.24M → $1.68M)
High-resolution chart · PNG

INBX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Inhibrx Biosciences Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
1,683,000
2,345,000
2,483,000
2,608,000
2,786,000
2,124,000
1,809,000
1,418,000
962,000
1,257,000
1,191,000
1,613,000
2,028,000
2,441,000
2,846,000
2,818,000
2,775,000
2,067,000
17,806,000
17,114,000
16,438,000
16,438,000
0
4,000
510,000
12,684,000
23,349,000
28,025,000
36,014,000
34,619,000
31,243,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.